603811 誠意藥業
按盤價 
7.600 +0.610 (+8.727%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.384 | 14.288 | 15.580 | 18.363 | 20.260 |
| 總資產報酬率 ROA (%) | 4.145 | 9.020 | 10.625 | 13.505 | 15.101 |
| 投入資產回報率 ROIC (%) | 4.686 | 10.175 | 11.970 | 15.856 | 16.550 | 邊際利潤分析 |
| 銷售毛利率 (%) | 69.712 | 64.177 | 68.424 | 70.875 | 73.846 |
| 營業利潤率 (%) | 24.478 | 25.894 | 25.105 | 28.609 | 25.109 |
| 息稅前利潤/營業總收入 (%) | 25.669 | 26.887 | 25.534 | 28.274 | 25.384 |
| 淨利潤/營業總收入 (%) | 21.506 | 24.128 | 24.609 | 24.674 | 21.758 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 73.561 | 68.551 | 73.783 | 80.894 | 88.859 |
| 價值變動淨收益/利潤總額(%) | 22.739 | 33.400 | 26.327 | 20.867 | 11.773 |
| 營業外收支淨額/利潤總額(%) | 0.298 | 0.088 | -0.359 | -0.524 | -0.777 | 償債能力分析 |
| 流動比率 (X) | 0.980 | 1.510 | 1.693 | 1.166 | 1.242 |
| 速動比率 (X) | 0.704 | 1.169 | 1.263 | 0.692 | 0.717 |
| 資產負債率 (%) | 32.795 | 36.780 | 36.540 | 24.470 | 26.580 |
| 帶息債務/全部投入資本 (%) | 22.936 | 25.754 | 27.342 | 13.030 | -- |
| 股東權益/帶息債務 (%) | 326.285 | 279.585 | 257.363 | 656.046 | 771.727 |
| 股東權益/負債合計 (%) | 204.184 | 171.272 | 173.186 | 304.777 | 272.433 |
| 利息保障倍數 (X) | 22.964 | 27.718 | 49.226 | -151.908 | 54.263 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 35.863 | 36.468 | 37.166 | 36.905 | 0.000 |
| 存貨周轉天數 (天) | 202.879 | 170.442 | 198.476 | 210.404 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
